of the eurasian economic union, drugs therapies are a variety of biological drugs and belong to high- tech drugs and must be registered without alternatives, according to the requirements of the decision of the council of the eurasian economic commissionibility of registering such drugs in the countries of the eurasian economic union preparations does not meet, e, modern requirements. uh, in particular, in our legislation there is no concept of technological and somatocellular drugs. this , in turn, creates barriers to the circulation of such drugs, therefore, it is necessary to further harmonize russian legislation with the law of the eurasian economic union and create special conditions for the registration and circulation of gene-cell drugs. eh, in this regard. uh, at the end of the twenty-first year at a meeting of the expert council on health, and the committee. federation for policy making, it was decided to establish a working group to improve the legal and regulatory regulation in the field of application of gene and cell technologies, the composition of the working group included. uh, senators and deputies of the state duma are leading experts. e, the working group has begun its work , already defined, an action plan is plann